BEAUTY GIANTS: ESTÉE LAUDER COMPANIES – WILLIAM LAUDER
to ending breast cancer by attending BCRF’s first-ever virtual Hot Pink Party. The event raised $5.3m for research, and we hope to see the same sustained commitment this fall.
Long-time BCC ambassador Elizabeth Hurley hosted the BCRF event. Just how important has Hurley been to the campaign over the years? Elizabeth has been the Global Ambassador for The Estée Lauder Companies’ Breast Cancer Campaign since 1995, when she first began working with my mother on her efforts. For Elizabeth, this has always been personal, as she lost her grandmother to breast cancer shortly before she began working on the campaign. She has truly used her global platform and passion for the cause to drive social good, inspiring people everywhere to rally around the campaign while raising funds and spreading very important messages about breast health and early detection. When she and my mother first started their work, people did not speak openly about breast cancer, and Elizabeth has really helped to de-stigmatise this.
As you mentioned, The BCC has raised more than $89m to support global research, education and medical services, with more than $73m funding 293 medical research grants through the Breast Cancer Research Foundation (BCRF). What is the campaign hoping to achieve this year? Over the last three decades we have worked tirelessly to achieve my mother’s vision: a world without breast cancer. Though we know the world has changed, our Breast Cancer Campaign’s steadfast commitment to end breast cancer, by uniting communities around the world to continue critical, lifesaving research, education and medical services in our lifetime is stronger than ever. We continue to rally people everywhere, all inspired by our mission. It’s #TimeToEndBreastCancer.
It has been well-reported that cancer treatments have been
OCTOBER 2020
postponed or cancelled during this period in many parts of the world. Diagnosis is also becoming more difficult as many people have been reluctant to visit doctors and hospitals to have mammograms and other tests. What would you say to reassure those cancer patients who have had their treatments postponed and what advice might you give those who are avoiding seeing their doctor or having tests – for fear of catching Covid-19 – at surgeries or at hospitals? Patients should be diligent about rescheduling cancelled appointments as soon as they can. Be aware of your own bodies and notice when changes happen. Take advantage of virtual visits and do what you can to see a doctor in person if you’re seriously concerned. The stark reality is that research
suggests delays in diagnosis and changes in treatment will inevitably have a negative impact on deaths or outcomes from cancer in the future. It’s difficult to predict the exact toll because of the geographic differences in virus outbreaks, as well as the challenges in obtaining data. However, this undoubtedly heightens the urgency to find better and more effective ways to diagnose and treat breast cancer patients during a time when research is experiencing unprecedented cuts. This is simply another urgent factor for why The Breast Cancer Campaign’s work remains even more critical this year.
The DF&TR industry has long played a significant role in fundraising and awareness for The BCC. However, this year as the travel industry has been crippled by Covid-19 it may not be able to support The BCC as in previous years. What advice would you give the global travel retail industry right now? Travel retail has certainly been greatly impacted by Covid-19. While this is undoubtedly an incredibly trying time for the industry, we at The Estée Lauder Companies believe in travel retail and the sustainability of this channel in the long term. For many years, travel retail has been a
champion of the campaign, and we look forward to its recovery so it can continue to positively impact this important work.
In two years, ELC will reach a 30-year milestone for The BCC. Do you have any idea what the campaign will achieve by then and how it will mark this significant anniversary? I am confident that as we mark this milestone in The BCC, we will continue to positively impact the lives of people globally through our work. We will continue to raise millions of dollars to fund research, education and medical services and support the brightest research minds and organisations all aligned to our mission. While we will likely honour the anniversary and all of the progress that has been made, we must still recognise that breast cancer is the most common cancer in women worldwide, and our commitment to ending breast cancer as a life-threatening disease will remain unwavering. «
“Breast cancer is the most common cancer in women worldwide, and our commitment to ending breast cancer as a life-threatening disease will remain unwavering.”
William P. Lauder, Estée Lauder Companies
TRBUSINESS 57
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78
